Product Images Trulicity
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 48 images provide visual information about the product associated with Trulicity NDC 50090-6571 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl500906571
Logo - logo
QR Code - qr v1
Figure - trulicity ifu 0point75 injection sites back v1
Figure - trulicity ifu 0point75 injection sites front v1
Figure - trulicity ifu 1point5 injection sites back v1
Figure - trulicity ifu 1point5 injection sites front v1
Figure - trulicity ifu 3mg injection sites v1
Figure - trulicity ifu 4point5mg injection sites v1
Figure - trulicity ifu check v1
Exclamation - trulicity ifu exclamation v1
Figure - trulicity ifu expiration location v2
Figure - trulicity ifu inspect v1
Locked - trulicity ifu locked v1
Figure - trulicity ifu prepare v1
Figure - trulicity ifu remove v1
Figure - trulicity ifu sup 0point75 f2 v3
Figure - trulicity ifu sup 0point75 f3 v3
Figure - trulicity ifu sup 0point75 f4 v3
Figure - trulicity ifu sup 0point75 f5 v3
Figure - trulicity ifu sup 0point75 pen parts v3
Figure - trulicity ifu sup 0point75 pen v3
Figure - trulicity ifu sup 1point5 f2 v3
Figure - trulicity ifu sup 1point5 f3 v3
Figure - trulicity ifu sup 1point5 f4 v3
Figure - trulicity ifu sup 1point5 f5 v3
Figure - trulicity ifu sup 1point5 pen parts v3
Figure - trulicity ifu sup 1point5 pen v3
Figure - trulicity ifu sup 3mg f2 v1
Figure - trulicity ifu sup 3mg f3 v1
Figure - trulicity ifu sup 3mg f4 v1
This text mentions the steps to determine if an injection is complete by observing the visibility of the gray plunger.*
Figure - trulicity ifu sup 3mg f5 v1
Figure - trulicity ifu sup 3mg pen parts v1
Figure - trulicity ifu sup 3mg pen v1
Figure - trulicity ifu sup 4point5 f2 v1
Figure - trulicity ifu sup 4point5 f3 v1
Figure - trulicity ifu sup 4point5 f4 v1
Figure - trulicity ifu sup 4point5 f5 v1
Figure - trulicity ifu sup 4point5 pen parts v1
Figure - trulicity ifu sup 4point5 pen v1
Figure - trulicity ifu unfold v1
Unlocked - trulicity ifu unlock v1
Figure 1 - trulicity pi f1 v2
Figure 2 - trulicity pi f2 v2
Figure 3 - trulicity pi f3 v3
Figure 4 - trulicity pi f4 v3
Figure 5 - trulicity pi f5 v2
Figure 6 - trulicity pi f6 v2
This text provides information about patients with an event (%), as well as the comparison between Placebo and Dulaglutide. The data includes percentages ranging from 10% to 20% for patients with an event. The text also mentions a hazard ratio (HR) of 0.88 and a 95% confidence interval (CI) of [0.79, 0.99] for Dulaglutide compared to Placebo. Additionally, it references a time of 6 years from randomization.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.